Sponsored by:

Nuclear Medicine: Page 383

Free educational site summarizes normal variants in PET, PET/CT
By AuntMinnie.com staff writers
MIAMI BEACH, FL - Nuclear medicine specialists from Boston have laid the groundwork for a free, interactive Web-based PET/CT imaging atlas. They offered a preview of the atlas in an electronic exhibit at the American Roentgen Ray Society meeting this week.
May 6, 2004
International Isotopes doubles revenue in Q1
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes of Idaho Falls, ID, reported sales of $743,325, more than doubling the revenue of $359,601 posted in the comparable quarter one year ago.
May 5, 2004
CTI revenues climb 30%
By AuntMinnie.com staff writers
CTI Molecular Imaging reported second-quarter net revenue of $106.3 million, up 30% compared with the $81.9 million turned in during the second quarter last year. For the period (end-March 31), the Knoxville, TN-based vendor had net income of $5.8 million, compared with net income of $4.8 million a year ago.
May 4, 2004
Draxis acquires remainder of Draxis Pharma
By AuntMinnie.com staff writers
Radiopharmaceutical firm Draxis Health of Mississauga, ON, has successfully completed its purchase of the remaining shares of Draxis Pharma, a contract manufacturing subsidiary. Draxis bought the shares from SGF Santé, which had held a 32.7% minority interest.
April 22, 2004
Dilon begins marketing breast gamma camera
By AuntMinnie.com staff writers
Dilon Technologies of Newport News, VA, has begun commercial production and sales of a new dedicated breast imaging gamma camera.
April 22, 2004
MDS Nordion launches Theryttrex in E.U
By AuntMinnie.com staff writers
Canadian radioisotope supplier MDS Nordion of Kanata, ON, has introduced Theryttrex, the company's radiopharmaceutical-grade yttrium-90 (Y-90) product, at the German Congress of Nuclear Medicine in Rostock, Germany.
April 21, 2004
Draxis closes unit share deal
By AuntMinnie.com staff writers
Radiopharmaceutical firm Draxis Health of Mississauga, ON, has successfully closed its offering of more than 3 million share units.
April 21, 2004
Scintimammography augments traditional cancer detection methods
By Shalmali Pal
Radiographically dense breasts continue to pose a challenge to women's imaging specialists. The alternative imaging options that have been proposed include computed radiography for mammography, as well as ultrasound, MRI, and scintimammography. A study in the latest issue of the Journal of Nuclear Medicine has suggested taking the latter modality one step further, with a dedicated breast camera.
April 19, 2004
2004 04 19 15 37 40 706
Cytogen to raise $26 million in stock sale
By AuntMinnie.com staff writers
Radiopharmaceutical developer Cytogen of Princeton, NJ, plans to raise $26 million in a registered direct offering of common stock. The company plans to sell 2.57 million shares of stock at $10.10 a share, with net proceeds to the company of $24 million.
April 15, 2004
SNM offers $25,000 grant to nuclear medicine technologists
By AuntMinnie.com staff writers
The Society of Nuclear Medicine Technologist Section (SNMTS) has launched its first grant program. Applicants may seek up to $25,000 to support a year's worth of research on radiation safety and practice management.
April 13, 2004
Cytogen adds to management team
By AuntMinnie.com staff writers
Biopharmaceutical developer Cytogen has appointed Thomas Lytle as senior vice president of sales and marketing.
April 8, 2004
Boston Life Sciences gets FDA OK for Altropane trial
By AuntMinnie.com staff writers
Pharmaceutical firm Boston Life Sciences has reached an agreement with the Food and Drug Administration for the phase III clinical trial of its radioimaging agent Altropane.
March 31, 2004
Previous Page
Page 383 of 439
Next Page